Bayer

September 26, 2017

The Future of BioManufacturing: Cell Line Engineering

August 25, 2017

The Future of BioManufacturing: The Promise of Perfusion

May 24, 2016

Further AgriBusiness Consolidation as Bayer Makes a $62B Bid for Monsanto

Last week German multinational Bayer put forward an all-cash $62B bid for American AgTech giant Monsanto, further emphasizing the unprecedented period of consolidation that the global […]
February 21, 2016

Evolution Infographic: The Rise & Diversification of Biologics

For our latest Data Visualisation project, the Evolution Global Team analysed historical new drug approval statistics and the current clinical trials pipeline to identify trends that […]